Aykut Eşki1, Gökçen Kartal Öztürk1, Figen Gülen1, Candan Çiçek2, Esen Demir1. 1. From the Department of Pediatric Pulmonology. 2. Department of Microbiology, Ege University Medical Faculty, Ege University Children's Hospital, Kazim Karabekir No: 9, Bornova, Izmir, Turkey.
Abstract
BACKGROUND: Influenza virus is one of the most common respiratory pathogens for all age groups and may cause seasonal outbreaks. Our aim was to identify risk groups and factors associated with severe clinical course including mortality in children with influenza-related lower respiratory tract infection (LRTI). METHODS: We conducted a retrospective study in children hospitalized with influenza virus LRTI from 2008 to 2018. Data on demographic features, influenza type, viral coinfection, primary and secondary bacterial infections (SBIs), time of onset of antiviral treatment, comorbidities, hospitalization length, pediatric intensive care unit admission/invasive mechanical ventilation (IMV) need and mortality were collected from medical records. RESULTS: There were 280 patients hospitalized with LRTI and median hospitalization length was 9 days. Congenital heart disease, neuromuscular disease, SBIs and late-onset antiviral treatment were independent risk factors for prolonged hospital stay (P < 0.05). Pediatric intensive care unit admission was present in 20.4% (57) of the patients and 17.1% (48) of all patients required IMV. SBIs, lymphopenia, neutrophilia, immunosuppression and human bocavirus coinfection were independent risk factors for IMV support (P < 0.05). Eighteen patients died and immunosuppression, lymphopenia and SBIs were independent risk factors for mortality (P < 0.05). CONCLUSIONS: Presence of comorbidity, SBIs, neutrophilia and lymphopenia at admission identified as risk factors for severe influenza infections including need for IMV and death. Although several studies showed that antiviral treatment reduce hospitalization, complications and mortality, there is a lack of prospective trials and patients for antiviral therapy should be carefully chosen by the clinician.
BACKGROUND:Influenza virus is one of the most common respiratory pathogens for all age groups and may cause seasonal outbreaks. Our aim was to identify risk groups and factors associated with severe clinical course including mortality in children with influenza-related lower respiratory tract infection (LRTI). METHODS: We conducted a retrospective study in children hospitalized with influenza virus LRTI from 2008 to 2018. Data on demographic features, influenza type, viral coinfection, primary and secondary bacterial infections (SBIs), time of onset of antiviral treatment, comorbidities, hospitalization length, pediatric intensive care unit admission/invasive mechanical ventilation (IMV) need and mortality were collected from medical records. RESULTS: There were 280 patients hospitalized with LRTI and median hospitalization length was 9 days. Congenital heart disease, neuromuscular disease, SBIs and late-onset antiviral treatment were independent risk factors for prolonged hospital stay (P < 0.05). Pediatric intensive care unit admission was present in 20.4% (57) of the patients and 17.1% (48) of all patients required IMV. SBIs, lymphopenia, neutrophilia, immunosuppression and human bocaviruscoinfection were independent risk factors for IMV support (P < 0.05). Eighteen patientsdied and immunosuppression, lymphopenia and SBIs were independent risk factors for mortality (P < 0.05). CONCLUSIONS: Presence of comorbidity, SBIs, neutrophilia and lymphopenia at admission identified as risk factors for severe influenza infections including need for IMV and death. Although several studies showed that antiviral treatment reduce hospitalization, complications and mortality, there is a lack of prospective trials and patients for antiviral therapy should be carefully chosen by the clinician.
Authors: Patrick S Walsh; David Schnadower; Yin Zhang; Sriram Ramgopal; Samir S Shah; Paria M Wilson Journal: JAMA Pediatr Date: 2022-09-19 Impact factor: 26.796
Authors: Yvette N Löwensteyn; Harish Nair; Marta C Nunes; Ichelle van Roessel; Femke S Vernooij; Joukje Willemsen; Louis J Bont; Natalie I Mazur Journal: EClinicalMedicine Date: 2021-06-10
Authors: Anna Cantarutti; Elisa Barbieri; Antonio Scamarcia; Luigi Cantarutti; Cristina Canova; Carlo Giaquinto Journal: Int J Environ Res Public Health Date: 2021-06-26 Impact factor: 3.390
Authors: Sophia C Mylonakis; Evangelia K Mylona; Markos Kalligeros; Fadi Shehadeh; Philip A Chan; Eleftherios Mylonakis Journal: Int J Environ Res Public Health Date: 2022-02-28 Impact factor: 3.390